243 related articles for article (PubMed ID: 23542376)
1. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.
Bentzen J; Kjellberg J; Thorgaard C; Engholm G; Phillip A; Storm HH
Eur J Cancer Prev; 2013 Nov; 22(6):569-76. PubMed ID: 23542376
[TBL] [Abstract][Full Text] [Related]
2. Modelling the healthcare costs of skin cancer in South Africa.
Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic status and non-melanoma skin cancer: a nationwide cohort study of incidence and survival in Denmark.
Steding-Jessen M; Birch-Johansen F; Jensen A; Schüz J; Kjær SK; Dalton SO
Cancer Epidemiol; 2010 Dec; 34(6):689-95. PubMed ID: 20638927
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and economic burden of nonmelanoma skin cancer.
Cakir BÖ; Adamson P; Cingi C
Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
[TBL] [Abstract][Full Text] [Related]
6. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.
Gordon LG; Rowell D
Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375
[TBL] [Abstract][Full Text] [Related]
7. Estimating the economic costs of skin cancer in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
[TBL] [Abstract][Full Text] [Related]
8. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
[TBL] [Abstract][Full Text] [Related]
9. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
10. Societal cost of skin cancer in Sweden in 2005.
Tinghög G; Carlsson P; Synnerstad I; Rosdahl I
Acta Derm Venereol; 2008; 88(5):467-73. PubMed ID: 18779884
[TBL] [Abstract][Full Text] [Related]
11. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
13. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
14. The impact of non-melanoma skin cancer.
Miller SJ
J Natl Compr Canc Netw; 2004 Jan; 2(1):2. PubMed ID: 19777690
[No Abstract] [Full Text] [Related]
15. Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Shakeshaft AP; Searles A; Perez D
PLoS One; 2016; 11(1):e0147665. PubMed ID: 26824695
[TBL] [Abstract][Full Text] [Related]
16. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
18. Analyzing the cost of preventing nonmelanoma skin cancer.
King SC; Chen S
J Invest Dermatol; 2009 Dec; 129(12):2745-6. PubMed ID: 19901945
[TBL] [Abstract][Full Text] [Related]
19. Mobile phone use and the risk of skin cancer: a nationwide cohort study in Denmark.
Poulsen AH; Friis S; Johansen C; Jensen A; Frei P; Kjaear SK; Dalton SO; Schüz J
Am J Epidemiol; 2013 Jul; 178(2):190-7. PubMed ID: 23788669
[TBL] [Abstract][Full Text] [Related]
20. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
